Moreover, BCL2 (an anti-apoptotic factor overexpressed and often mutated in DLBCL) (40) was also upregulated in our DLBCL cohort and its expression was correlated with that of CASP3 and CASP8 (two apoptosis regulators). Here, CASP8 is linked to diffuse large B-cell lymphoma.